NanoDimension

  • Alveo Energy
  • ARMO Biosciences
  • Bind
  • Click Diagnostics
  • Crocus Technology
  • Emulate
  • IonPath
  • Muse Bio
  • Pulse Therapeutics
  • SBA Materials
  • Selecta Biosciences
  • Tarveda
  • Twist Bioscience
  • View Inc.
  • Xtellus

Alveo Energy

Alveo Energy is developing a completely new high power, long cycle life, low-cost battery technology for stationary and select transit applications.

Company

ND Board Member

Dr. Luc Bauer

Location

Palo Alto, CA

CEO

Dr. Colin Wessels

ARMO Biosciences

ARMO Biosciences is developing immunotherapies for the treatment of cancer, cardiovascular disease, fibrosis and inflammation.

Company

Founder

Dr. Peter Van Vlasselaer
Dr. Martin Oft
Dr. John Mumm

ND Board Member

Location

Redwood City, CA

CEO

Dr. Peter Van Vlasselaer

Bind

BIND Therapeutics is a clinical-stage biopharmaceutical company developing a new class of highly selective targeted therapeutics called Accurins.

Company

Founder

Dr. Bob Langer
Dr. Omid Farokhzad

ND Board Member

Location

Cambridge, MA, USA

CEO

Andrew Hirsch

Click Diagnostics

Click Diagnostics is in stealth mode

Company

Click Diagnostics

Founder

Dr. Adam de la Zerda

ND Board Member

Eric Moessinger

Location

Menlo Park, CA, USA

CEO

 

Crocus Technology

Crocus Technology is a leading developer of magnetically enhanced semiconductor technology.

Company

ND Board Member

Location

Grenoble, France
Sunnyvale, CA, USA

CEO

Michel Desbard

Emulate

Emulate is creating a new living platform to emulate human biology.

Company

Founder

Dr. Donald Ingber
Dr. Geraldine Hamilton
Dr. Daniel Levner
James Coon
Greg Williams

ND Board Member

Location

Cambridge, MA, USA

CEO

James Coon

IonPath

Ionpath is transforming pathology with multiplexed ion beam imaging.

Company

IonPath

Founder

Dr. Garry Nolan
Dr. Michael Angelo
Dr. Sean Bendall
Dr. Harris Fienberg

ND Board Member

Eric Moessinger

Location

Menlo Park, CA, USA

CEO

Dr. Harris Fienberg

Muse Bio

Muse Bio is developing a highly scalable, super efficient and economical approach to precision genome engineering using CRISPR technology.

Company

Founder

Dr. Ryan Gill
Dr. Tanya Lipscomb
Dr. Andrew Garst

ND Board Member

Eric Moessinger

Location

Boulder, CO

CEO

Dr. Ryan Gill

Pulse Therapeutics

Pulse Therapeutics is a medical device company developing magnetics-based products to enhance the delivery of clot-busting drugs in ischemic stroke.

Company

Pulse Therapeutics

Founder

Dr. Francis (Duke) M. Creighton
Dr. Rogers C. Ritter

ND Board Member

Location

St. Louis, MO

CEO

Sean Morris

SBA Materials

SBA Materials is developing functional porous inorganic and inorganic/organic hybrid materials for a wide range of technologies.

Company

ND Board Member

Location

San Jose, CA, USA
Albuquerque, NM, USA

CEO

Dr. Hash Pakbaz

Selecta Biosciences

Selecta Biosciences is a clinical-stage biotechnology company developing an entirely new class of targeted vaccines that induces an antigen-specific immune activation or antigen-specific immune tolerance for therapeutic and prophylactic applications.

Company

Founder

Dr. Bob Langer
Dr. Omid Farokhzad
Dr. Uli von Andrian

ND Board Member

Location

Watertown, MA, USA

CEO

Dr. Werner Cautreels

Tarveda

Tarveda Therapeutics is a biopharmaceutical company discovering new classes of medicines using a proprietary integrative approach to design superior drugs.

Company

Founder

Dr. Bob Langer
Dr. Omid Farokhzad
Dr. Stephen Lippard

ND Board Member

Location

Watertown, MA, USA

CEO

Drew Fromkin

Twist Bioscience

Twist Bioscience makes synthetic DNA for health and sustainability.

Company

Founder

Dr. Emily Leproust
Dr. Bill Banyai
Dr. Bill Peck

ND Board Member

Location

San Francisco, CA

CEO

Dr. Emily Leproust

View Inc.

View Inc. manufactures View Dynamic Glass, an intelligent glass system for residential and commercial buildings.

Company

ND Board Member

Location

Milpitas, CA, USA
Olive Branch, MS, USA

CEO

Dr. Rao Mulpuri

Xtellus

Xtellus is a manufacturer of wavelength blockers and wavelength selective switches for reconfigurable optical add/drop multiplexers in fiber-optic networks.

Company

Xtellus

Location

Morris Plains, NJ, USA

Acquired by Oclaro (Nasdaq: OCLR) in 2009